1 completed, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow Cardiovascular Events: new trials by email Literature Review of Cardiovascular Events trials Research Report on Cardiovascular Events
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Statins to Prevent Cancer Associated Blood Clots Rosuvastatin, Placebo Drug - Venous Thromboembolism, Cancer | Phase 4 | Recruiting | Brigham and Women's Hospital | 4000 | 2026-06-11 | 2026-09-16 |
| Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients Sevelamer HCl, Calcium-based phosphate binder - Hemodialysis, Hyperphosphatemia | Phase 4 | Completed | Chugai Pharma Taiwan | 166 | 2007-06-01 | 2014-08-05 |
Hyperphosphatemia (1) · Neoplasms (1) · Pulmonary Embolism (1) · Venous Thromboembolism (1)
Cardiovascular Diseases (1) · Embolism (1) · Embolism and Thrombosis (1) · Lung Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Phosphorus Metabolism Disorders (1) · Respiratory Tract Diseases (1) · Thromboembolism (1) · Vascular Diseases (1)
Calcium Carbonate (1) · Rosuvastatin Calcium (1) · Sevelamer (1) · calcium acetate (1)
Brigham and Women's Hospital (1) · Chugai Pharma Taiwan (1)
United States (1)
Chiu-Ching Huang, Professor (1)
UG3HL176627 (1)